Identify cell surface protein ligand candidates for understudied adhesion GPCRs using a sensitive cell-based approach
使用敏感的基于细胞的方法识别用于正在研究的粘附 GPCR 的细胞表面蛋白配体候选物
基本信息
- 批准号:10452320
- 负责人:
- 金额:$ 14.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAffinityAntibodiesAntigen-Presenting CellsBackBindingBiological AssayBiological ProcessC-terminalCD3 AntigensCell LineCell Surface ProteinsCell membraneCell surfaceCellsCharacteristicsCollectionCustomDataDevelopmentDiseaseDrug DesignEnzyme-Linked Immunosorbent AssayFlow CytometryFutureG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGenesHumanIndividualIntegral Membrane ProteinInterleukin-10Interleukin-4LeadLigand BindingLigandsMalignant NeoplasmsMeasuresMediatingMethodsMicroscopeModelingMonitorMovementMusMusculoskeletal DiseasesN-terminalNatureNoiseOpen Reading FramesOrphanPatternPhysiologicalPlayProductionProtein ArrayProteinsPuromycinReceptor CellReceptor SignalingRetroviral VectorRoleSensitivity and SpecificitySignal TransductionStainsSurfaceT-Cell ReceptorT-LymphocyteTertiary Protein StructureTestingTh2 Cellsadhesion receptorbasecDNA Librarycytokineextracellularhuman diseasenovelprotein protein interactionreceptorreceptor bindingstable cell linetherapeutic targettwo-dimensional
项目摘要
PROJECT SUMMARY/ABSTRACT
Adhesion G protein-coupled receptors (aGPCRs) are a group of 33 poorly characterized non-olfactory GPCRs
with distinct features including autocatalytic processing and large extracellular regions. aGPCRs are involved
in a myriad of biological processes and some of them are associated with diseases, especially a wide range of
cancers. The extracellular regions of many of the aGPCRs contain domains that are known to be involved in
protein-protein interactions, suggesting that binding to cell surface protein ligands may play an important role in
their mechanisms of action. The majority of aGPCRs, however, are orphan receptors without known ligands.
Identification of ligands for these aGPCRs should help understand their physiological functions and roles in
cancer development. A major challenge for identifying ligands involved in ligand-receptor interactions at the
cell-cell interface is that they tend to bind their receptors very weakly and currently available methods do not
have enough sensitivity. To overcome this, we propose to employ a novel and highly sensitive cell-based
approach to identify protein ligands for 17 understudied orphan aGPCRs. The feasibility of the approach has
been tested using model ligands and receptors that are known bind to each other with low affinities. We will
use the cell-based approach to screen a collection of transmembrane proteins to identify ligand candidates for
the aGPCRs. Ligand candidates identified in this study will pave the way for more in-depth characterization of
their bindings to respective aGPCRs and the functional consequences of the bindings in future studies.
项目总结/摘要
粘附G蛋白偶联受体(aGPCR)是一组33个特征不明显的非嗅觉GPCR
具有独特的特征,包括自催化加工和大的细胞外区域。aGPCR涉及
在无数的生物过程中,其中一些与疾病有关,特别是广泛的
癌的许多aGPCR的细胞外区域含有已知参与细胞凋亡的结构域。
蛋白质-蛋白质相互作用,表明与细胞表面蛋白质配体的结合可能在
他们的行动机制。然而,大多数aGPCR是孤儿受体,没有已知的配体。
这些aGPCR的配体的鉴定应该有助于理解它们的生理功能和作用,
癌症发展鉴定参与配体-受体相互作用的配体的一个主要挑战是,
细胞-细胞界面的缺点是它们倾向于非常弱地结合它们的受体,并且目前可用的方法不
要有足够的敏感度。为了克服这一点,我们建议采用一种新的和高度敏感的细胞为基础的
方法鉴定17个未充分研究的孤儿aGPCR的蛋白质配体。该方法的可行性
已经使用已知以低亲和力彼此结合的模型配体和受体进行了测试。我们将
使用基于细胞的方法来筛选跨膜蛋白的集合,以鉴定配体候选物,
aGPCR。在这项研究中确定的配体候选者将为更深入地表征
它们与各自的aGPCR的结合以及在未来研究中结合的功能后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhengyu Ma其他文献
Zhengyu Ma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhengyu Ma', 18)}}的其他基金
Identify receptors for B7 family immune checkpoint orphan ligands using a novel cellbased approach
使用新型细胞方法识别 B7 家族免疫检查点孤儿配体的受体
- 批准号:
10058052 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 14.2万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 14.2万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 14.2万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 14.2万 - 项目类别:














{{item.name}}会员




